Biggest News Aggregation in the World
📰 Seqirus Pty News

Seqirus Pty News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Seqirus Pty. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Glenmark's Ryaltris® nasal spray now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age

Glenmarks Ryaltris® nasal spray now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age News provided by Share this article Share this article The launch will ensure much-needed access to a novel fixed-dose combination nasal spray for this chronic condition This marks Glenmarks first innovative product approval in the European Union MUMBAI, India, April 26, 2021 /PRNewswire/ -- Glenmark Pharmaceuticals Limited, a research-led, global integrat...
United Kingdom Czech Republic South Korea South Africa L Vivs Ka Oblast Saudi Arabia

Glenmarks Ryaltris®- innovative single nasal spray, ready to market in Russia

Glenmarks Ryaltris®- innovative single nasal spray, ready to market in Russia MUMBAI, India, Feb. 22, 2021 /PRNewswire/ -- Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S A, received marketing approval from the Ministry of Health of the Russian Federation for its innovative Ryaltris® Nasal Spray - a novel fixed-dose combination nasal spray. This paves the way for commercial...
United States South Africa Saudi Arabia Russian Federation Csaba Kantor Glenmarks Ryaltris

Glenmark Pharmaceuticals and Menarini enter into Exclusive Licensing Agreement for commercializing Ryaltris™ Nasal Spray

Glenmark Pharmaceuticals and Menarini enter into Exclusive Licensing Agreement for commercializing Ryaltris™ Nasal Spray Posted On: 2020-12-22 20:36:41 (Time Zone: Arizona, USA) Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Menarini Group (Menarini) for commercializing its innovative nasal spray Ryaltris™ across ...
South Africa L Vivs Ka Oblast Yu Han Saudi Arabia General Saudi Arabia South Korea

Glenmark Pharmaceuticals and Menarini enter into exclusive licensing agreement for commercializing Ryaltris™ nasal spray across numerous markets throughout Europe

Glenmark Pharmaceuticals Ltd Glenmark Pharmaceuticals and Menarini enter into exclusive licensing agreement for commercializing Ryaltris™ nasal spray across numerous markets throughout Europe ANI | Updated: Dec 23, 2020 11:14 IST Mumbai (Maharashtra) [India] December 23 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty SA, has en...
South Africa L Vivs Ka Oblast Yu Han Saudi Arabia General Saudi Arabia South Korea
Source: aninews.in

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science